Evidence map›Paper›PMID 29159096›Full record

ArticleJournal of clinical & translational endocrinology2014

Use of an integrated strip-free blood glucose monitoring system increases frequency of self-monitoring and improves glycemic control: Results from the ExAct study.

Alberto Maran, Diethelm Tschoepe, Maurizio Di Mauro, William A Fisher, Kurt Loeffler, Iris Vesper, Sandra Bloethner, Oliver Mast, Joerg Weissmann, Ildikó Amann-Zalán and 4 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical & translational endocrinology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Alberto MaranDepartment of Medicine, University of Padua, Padua, Italy.
Diethelm TschoepeHeart and Diabetes Center Nordrhein-Westfalen, Ruhr University of Bochum, Bad Oeynhausen, Germany.
Maurizio Di MauroDepartment of Medical and Pediatric Sciences, University of Catania, Policlinico 'G. Rodolico', Catania, Italy.
William A FisherDepartment of Psychology, Western University, London, Canada.
Kurt LoefflerAccovion GmbH, Eschborn, Germany.
Iris VesperRoche Diagnostics GmbH, Mannheim, Germany.
Sandra BloethnerRoche Diagnostics Deutschland GmbH, Mannheim, Germany.
Oliver MastRoche Diagnostics GmbH, Mannheim, Germany.
Joerg WeissmannRoche Diagnostics Deutschland GmbH, Mannheim, Germany.
Ildikó Amann-ZalánRoche Molecular Systems, Inc., Pleasanton, CA, USA.
Annette MoritzRoche Diagnostics GmbH, Mannheim, Germany.
Christopher G ParkinCGParkin Communications, Inc., 219 Red Rock Road, Boulder City, NV 89005, USA.
Taylor KohutDepartment of Psychology, Western University, London, Canada.
Iain CranstonPortsmouth Hospitals NHS Trust, Queen Alexandra Hospital, Cosham, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsWe investigated the impact of using an integrated, strip-free system compared to the use of single-strip systems on testing frequency and glycemic control in individuals with insulin-treated diabetes.

methodsThis multinational, comparative, cluster-randomized, observational study included 311 patients with type 1 and insulin-treated type 2 diabetes who were performing SMBG at suboptimal frequencies. Sites were cluster-randomized to "integrated strip-free" system (EXP group) or any "single-strip" system (CNL group). Testing frequency and HbA1c were measured at baseline, 12 weeks and 24 weeks.

resultsAt week 24, the EXP group showed an increase in SMBG frequency from baseline of 4.17 tests/week (95% CI 2.76, 5.58) compared with an increase of 0.53 tests/week (95% CI -0.73, 1.79) among CNL patients, resulting in a between-group difference of 3.63 tests/week (

conclusionsThe use of an integrated, strip-free SMBG system improved testing adherence and was associated with improvements in glycemic control.

Indexed as

AdherenceGlycemic controlHbA1cInsulinIntegrated strip-free systemSelf-monitoring of blood glucoseSMBGTesting frequencyType 1 diabetesType 2 diabetes

Identifiers

PMID29159096
PMCPMC5684965

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.